Join
Live feed
·
INSIDERFilingvia Quantisnow
Avenue Therapeutics Inc. logo

SEC Form 4: Kranzler Jay D was granted 69,020 shares, increasing direct ownership by 107% to 133,683 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATXI (Avenue Therapeutics Inc.) and more on Quantisnow.

SEC Form 4: Kranzler Jay D was granted 69,020 shares, increasing direct ownership by 107% to 133,683 units | Quantisnow